BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 15007304)

  • 1. Increased serum concentrations and surface expression on peripheral white blood cells of decay-accelerating factor (CD55) in patients with active ulcerative colitis.
    Makidono C; Mizuno M; Nasu J; Hiraoka S; Okada H; Yamamoto K; Fujita T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):152-8. PubMed ID: 15007304
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stool decay-accelerating factor as a marker for monitoring the disease activity during leukocyte apheresis therapy in patients with refractory ulcerative colitis.
    Kohno H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Inaba T; Yamamoto K; Okada H; Fujita T; Shiratori Y
    J Gastroenterol Hepatol; 2005 Jan; 20(1):73-8. PubMed ID: 15610450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced expression of decay accelerating factor and CD59/homologous restriction factor 20 on the colonic epithelium of ulcerative colitis.
    Uesu T; Mizuno M; Inoue H; Tomoda J; Tsuji T
    Lab Invest; 1995 May; 72(5):587-91. PubMed ID: 7538183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of serum soluble TNF-alpha receptors I and II levels with disease activity in patients with ulcerative colitis.
    Hanai H; Watanabe F; Yamada M; Sato Y; Takeuchi K; Iida T; Tozawa K; Tanaka T; Maruyama Y; Matsushita I; Iwaoka Y; Saniabadi A
    Am J Gastroenterol; 2004 Aug; 99(8):1532-8. PubMed ID: 15307873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Difference in Ulex europaeus agglutinin I-binding activity of decay-accelerating factor detected in the stools of patients with colorectal cancer and ulcerative colitis.
    Okazaki H; Mizuno M; Nasu J; Makidono C; Hiraoka S; Yamamoto K; Okada H; Fujita T; Tsuji T; Shiratori Y
    J Lab Clin Med; 2004 Mar; 143(3):169-74. PubMed ID: 15007307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adsorptive depletion of elevated proinflammatory CD14+CD16+DR++ monocytes in patients with inflammatory bowel disease.
    Hanai H; Iida T; Takeuchi K; Watanabe F; Yamada M; Kikuyama M; Maruyama Y; Iwaoka Y; Hirayama K; Nagata S; Takai K
    Am J Gastroenterol; 2008 May; 103(5):1210-6. PubMed ID: 18177452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patients with active inflammatory bowel disease lack immature peripheral blood plasmacytoid and myeloid dendritic cells.
    Baumgart DC; Metzke D; Schmitz J; Scheffold A; Sturm A; Wiedenmann B; Dignass AU
    Gut; 2005 Feb; 54(2):228-36. PubMed ID: 15647187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased circulating platelet-neutrophil, platelet-monocyte complexes, and platelet activation in patients with ulcerative colitis: a comparative study.
    Pamuk GE; Vural O; Turgut B; Demir M; Umit H; Tezel A
    Am J Hematol; 2006 Oct; 81(10):753-9. PubMed ID: 16941615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different regulation of eosinophil activity in Crohn's disease compared with ulcerative colitis.
    Lampinen M; Backman M; Winqvist O; Rorsman F; Rönnblom A; Sangfelt P; Carlson M
    J Leukoc Biol; 2008 Dec; 84(6):1392-9. PubMed ID: 18801925
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depletion of endothelial progenitor cells in the peripheral blood of patients with ulcerative colitis.
    Masuda J; Mitsuyama K; Yamasaki H; Takedatsu H; Okamura T; Andoh A; Murohara T; Asahara T; Sata M
    Int J Mol Med; 2007 Feb; 19(2):221-8. PubMed ID: 17203195
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Testing of multiple samples increases the sensitivity of stool decay-accelerating factor test for the detection of colorectal cancer.
    Mizuno M; Mizuno M; Iwagaki N; Nasu J; Okazaki H; Yamamoto K; Okada H; Tsuji T; Fujita T; Shiratori Y
    Am J Gastroenterol; 2003 Nov; 98(11):2550-5. PubMed ID: 14638362
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of acute psychologic stress on systemic and rectal mucosal measures of inflammation in ulcerative colitis.
    Mawdsley JE; Macey MG; Feakins RM; Langmead L; Rampton DS
    Gastroenterology; 2006 Aug; 131(2):410-9. PubMed ID: 16890594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Spontaneous aggregation of leukocytes in active ulcerative colitis might be ICAM-1 dependent.
    Vainer B; Berliner S; Nielsen OH
    Inflamm Res; 2004 Sep; 53(9):458-61. PubMed ID: 15550998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma total homocysteine in the active stage of ulcerative colitis.
    Drzewoski J; Gasiorowska A; Małecka-Panas E; Bald E; Czupryniak L
    J Gastroenterol Hepatol; 2006 Apr; 21(4):739-43. PubMed ID: 16677162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of interleukin-1b and tumor necrosis factor--a by peripheral blood human mononuclear cells in active and inactive stages of ulcerative colitis.
    Nikolopoulou V; Katsakoulis E; Tsiotos P; Thomopoulos K; Salsaa B; Zoumbos N
    Z Gastroenterol; 1995 Jan; 33(1):9-12. PubMed ID: 7886987
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decay-accelerating factor (DAF) in stool specimens as a marker of disease activity in patients with ulcerative colitis (UC).
    Inaba T; Mizuno M; Ohya S; Kawada M; Uesu T; Nasu J; Takeuchi K; Nakagawa M; Okada H; Fujita T; Tsuji T
    Clin Exp Immunol; 1998 May; 112(2):237-41. PubMed ID: 9649185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early expression changes of complement regulatory proteins and C5A receptor (CD88) on leukocytes after multiple injury in humans.
    Amara U; Kalbitz M; Perl M; Flierl MA; Rittirsch D; Weiss M; Schneider M; Gebhard F; Huber-Lang M
    Shock; 2010 Jun; 33(6):568-75. PubMed ID: 19864971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transforming growth factor-beta1 and its receptors in patients with ulcerative colitis.
    Stadnicki A; Machnik G; Klimacka-Nawrot E; Wolanska-Karut A; Labuzek K
    Int Immunopharmacol; 2009 Jun; 9(6):761-6. PubMed ID: 19285572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resistin is an inflammatory marker of inflammatory bowel disease in humans.
    Konrad A; Lehrke M; Schachinger V; Seibold F; Stark R; Ochsenkühn T; Parhofer KG; Göke B; Broedl UC
    Eur J Gastroenterol Hepatol; 2007 Dec; 19(12):1070-4. PubMed ID: 17998831
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet-leucocyte aggregates form in the mesenteric vasculature in patients with ulcerative colitis.
    Irving PM; Macey MG; Feakins RM; Knowles CH; Frye JN; Liyanage SH; Dorudi S; Williams NS; Rampton DS
    Eur J Gastroenterol Hepatol; 2008 Apr; 20(4):283-9. PubMed ID: 18334871
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.